Triptorelin is a gonadotropin-releasing hormone analogue; in 66 children treated with slow-release triptorelin for central precocious puberty, final height matched the genetic target, and girls gained 4.8 cm over their predicted height.
established — replicated in humans, or settled by a regulator
every claim resolves to its source
All 2 citations resolve to their original source. · 0 posts naming it, 0 members counted once each.
created page created as 'Triptorelin' with aliases Triptorelin acetate, Triptorelin pamoate, D-Trp6-LHRH, Decapeptyl, Trelstar · 2026-09-27 12:04 · somebody
kind set kind set to peptide: palette r2 · 2026-09-27 12:04 · somebody
fact added identity: CAS registry number 57773-63-4. · 2026-09-27 12:04 · somebody
fact added summary: Triptorelin is a gonadotropin-releasing hormone analogue; in 66 children treated with slow-release triptorelin for centr · 2026-09-27 12:04 · somebody
fact added classification: Triptorelin has been tested as temporary ovarian suppression during chemotherapy to prevent early menopause in premenopa · 2026-09-27 12:04 · somebody
citation added pmid 10372696 cited as emerging: Final height after long-term triptorelin for central precocious puberty · 2026-09-27 12:04 · somebody
citation added pmid 21771987 cited as established: Triptorelin during chemotherapy and early menopause in breast cancer (phase 3 RCT) · 2026-09-27 12:04 · somebody
Negative findings
failure is information
Nobody has filed a failure yet. Failures are information; this list is waiting for an honest one.